Taurine Levels Don't Decline With Age in Humans, New Study Finds
A study of 137 men aged 20–93 found no link between circulating taurine and age, muscle health, or mitochondrial function.
Summary
A 2025 study in Aging Cell challenges the hypothesis that taurine deficiency drives human aging. Researchers measured serum taurine in 137 men (ages 20–93, both active and inactive) and found no correlation between taurine levels and age, muscle mass, strength, physical performance, body composition, insulin sensitivity, or mitochondrial function. While prior animal studies showed taurine declining with age and supplementation extending lifespan in worms and mice, this human data suggests the relationship does not translate directly. The findings caution against extrapolating animal taurine research to humans and question whether taurine supplementation would meaningfully slow aging or improve healthspan in the general adult population.
Detailed Summary
A landmark 2023 study by Singh et al. proposed that taurine deficiency is a conserved driver of aging across species, including humans, sparking significant interest in taurine supplementation as a longevity intervention. That study showed declining taurine levels with age in mice and monkeys, and that restoring taurine extended lifespan in C. elegans and mice while improving healthspan markers in primates. However, the human data in that paper was limited, lacking participants over 65 and potentially driven by individuals under 20.
To directly test the taurine-aging hypothesis in humans, Marcangeli, Cefis, and colleagues performed a secondary analysis of a deeply phenotyped cohort of 137 men aged 20 to 93, comprising 49 physically inactive and 88 physically active individuals. Participants underwent a comprehensive battery of assessments including dual-energy X-ray absorptiometry (DXA) and peripheral quantitative computed tomography (pQCT) for body and muscle composition, multiple validated physical performance tests (6-minute walk test, Timed Up and Go, 30-second sit-to-stand, and step test), maximal strength and power measurements, and vastus lateralis muscle biopsies for mitochondrial respiration, reactive oxygen species production, and calcium retention capacity.
The results were uniformly negative with respect to the taurine-aging hypothesis. Serum taurine concentrations showed no association with age across the full adult lifespan studied. Taurine levels did not differ between physically active and inactive participants, consistent with earlier literature. No significant correlations emerged between taurine and any measure of physical performance, muscle mass, muscle strength, or lower limb power. Body composition metrics—total lean and fat mass—were likewise unrelated to taurine. Insulin sensitivity indices (HOMA-IR, QUICKI), fructosamine, and the inflammatory marker CRP were all uncorrelated with taurine. Strikingly, a significant negative correlation was observed between taurine and step test performance, a direction opposite to what the deficiency hypothesis would predict. Mitochondrial parameters including maximal respiration, ROS production, and calcium handling also showed no relationship with circulating taurine.
These findings carry important implications for the longevity field. While taurine biology in rodents and non-human primates may genuinely influence aging processes, taurine metabolism appears to differ meaningfully between species. Human muscle taurine levels, for instance, do not increase with supplementation as readily as in rodents. The current study provides the most comprehensive human dataset to date directly testing whether circulating taurine tracks with key aging phenotypes, and the answer is a consistent null result across dozens of outcomes.
Caveats include the all-male cohort, which limits generalizability to women, and the cross-sectional design, which cannot rule out complex longitudinal dynamics. The study also relied on serum rather than tissue taurine, though serum levels were within the range reported by Singh et al. These limitations notwithstanding, the breadth of null findings across multiple physiological domains represents a substantial challenge to taurine deficiency as a primary human aging driver.
Key Findings
- Serum taurine showed no correlation with age in men aged 20–93, contradicting the deficiency-aging hypothesis.
- No association was found between taurine and muscle mass, strength, power, or any physical performance test.
- Mitochondrial respiration, ROS production, and calcium handling were all unrelated to circulating taurine levels.
- Insulin sensitivity (HOMA-IR, QUICKI), fructosamine, and CRP were unassociated with serum taurine.
- Active and inactive men had statistically identical serum taurine concentrations (~92 vs. ~97 μM, p=0.338).
Methodology
Cross-sectional secondary analysis of 137 men (ages 20–93; 49 inactive, 88 active) from a prior study. Participants underwent DXA, pQCT, validated physical performance tests, blood biomarkers, and vastus lateralis biopsies for mitochondrial function assessment. Pearson correlations tested associations between serum taurine and all outcomes.
Study Limitations
The cohort was exclusively male, limiting generalizability to women. The cross-sectional design cannot capture longitudinal changes in taurine across an individual's lifespan. Serum taurine may not fully reflect tissue-level taurine status, though values were consistent with prior human reference ranges.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.